(Q41139770)

27 September 2017

1 reference

title

Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension (English)

1 reference

27 September 2017

G L Plosker

1

1 reference

27 September 2017

D Faulds

series ordinal

2

1 reference

27 September 2017

publication date

1 August 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

52

1 reference

27 September 2017

issue

2

1 reference

27 September 2017

page(s)

232-253

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199652020-00009

27 September 2017

exact match

0 references

cites work

Inhibitory effect of nisoldipine on angiotensin-II-induced renal actions in anesthetized dogs.

1 reference

12 December 2020

Effects of nisoldipine on endothelin-1- and angiotensin II-induced immediate/early gene expression and protein synthesis in adult rat ventricular cardiomyocytes

1 reference

12 December 2020

Stimulated leukocyte adhesion in coronary microcirculation is reduced by a calcium antagonist

1 reference

12 December 2020

Controversies regarding the recommendations of the Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Effect of nisoldipine on red cell deformability and platelet aggregation in stroke patients

1 reference

12 December 2020

Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells

1 reference

12 December 2020

Cardiac structural remodelling after treatment of spontaneously hypertensive rats with nifedipine or nisoldipine

1 reference

12 December 2020

Trough/peak ratios for antihypertensive agents. The issues in perspective

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic interactions during multiple-dose administration of nisoldipine and propranolol

1 reference

12 December 2020

Effects of a chronic treatment by nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form

1 reference

12 December 2020

Guidelines for treating hypertension: improved care or retarded progress?

1 reference

12 December 2020

Calcium antagonists in comparison: view of the pharmacologist

1 reference

12 December 2020

A practical guideline for management of hypertension in patients with diabetes

1 reference

12 December 2020

Changes in cardiovascular mass, left ventricular pumping ability and aortic distensibility after calcium antagonists in Wistar-Kyoto and spontaneously hypertensive rats.

1 reference

12 December 2020

In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil

1 reference

12 December 2020

Effect of calcium antagonists on endothelin-induced contraction of isolated human resistance arteries: differences related to site of origin.

1 reference

12 December 2020

Nifedipine and nisoldipine in hypertensive diabetics

1 reference

12 December 2020

The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon

1 reference

12 December 2020

Pharmacokinetics of Nisoldipine Coat--Core Formulation in Subjects with Liver Cirrhosis

1 reference

12 December 2020

The effect of nisoldipine on renal function in the long-term treatment of hypertension in patients with and without renal impairment.

1 reference

12 December 2020

Clinical pharmacology of nisoldipine coat core

1 reference

12 December 2020

Renoprotective effect of nisoldipine in rats with severe hypertension

1 reference

12 December 2020

Contrasting effects of calcium antagonists vs. arterial vasodilators on cardiac anatomy and sympathetic activity in spontaneously hypertensive rats

1 reference

12 December 2020

Multiple Dose Pharmacokinetics of Four Different Doses of Nisoldipine in Hypertensive Patients

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol.

1 reference

12 December 2020

Comparative cytoprotective effect of dihydropyridine calcium channel blockers against the toxicity of oxidized low density lipoprotein for cultured lymphoid cells

1 reference

12 December 2020

Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies

1 reference

12 December 2020

Calcium antagonists should continue to be used for first-line treatment of hypertension

1 reference

12 December 2020

Effects of calcium- and ETA-receptor antagonists on endothelin-induced vasoconstriction and levels of endothelin in the human internal mammary artery

1 reference

12 December 2020

Should dihydropyridines be used as first-line drugs in the treatment of hypertension? The con side

1 reference

12 December 2020

Effect of nisoldipine on atherosclerosis in the cholesterol fed rabbit: endothelium dependent relaxation and aortic cholesterol content.

1 reference

12 December 2020

Controversies in the diagnosis and treatment of hypertension: a personal review of JNC V.

1 reference

12 December 2020

Case-control study, meta-analysis, and bouillabaisse: putting the calcium antagonist scare into context

1 reference

12 December 2020

Rapid development of tolerance to the antihypertensive effect of nisoldipine

1 reference

12 December 2020

A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin

1 reference

12 December 2020

The actions of nifedipine and nisoldipine on the contractile activity of human coronary arteries and human cardiac tissue in vitro

1 reference

12 December 2020

Effects of dihydropyridines and inorganic calcium blockers on aggregation and on intracellular free calcium in platelets

1 reference

12 December 2020

Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine

1 reference

12 December 2020

Absence of antioxidant effects of nifedipine and diltiazem on myocardial membrane lipid peroxidation in contrast with those of nisoldipine and propranolol

1 reference

12 December 2020

Effect of the calcium channel blocker nisoldipine on the progression of chronic renal failure in man

1 reference

12 December 2020

Efficacy and safety of nisoldipine coat core in the management of angina pectoris, systemic hypertension, and ischemic ventricular dysfunction

1 reference

12 December 2020

Diabetes and hypertension. Australian Diabetes Society position statement.

1 reference

12 December 2020

Inhibitory effects of nisoldipine on serotonin and potassium induced contractions of porcine coronary and femoral arteries

1 reference

12 December 2020

The interactions between nisoldipine and two beta-adrenoceptor antagonists-atenolol and propranolol

1 reference

12 December 2020

Direct vascular and myocardial effects of nisoldipine.

1 reference

12 December 2020

The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

1 reference

12 December 2020

Vascular selectivity of seven prototype calcium antagonists: a study at the single cell level

1 reference

12 December 2020

Grapefruit juice and drugs. How significant is the interaction?

1 reference

12 December 2020

Nisoldipine inhibits adrenergic responses in the hindquarters vascular bed of the cat.

1 reference

12 December 2020

Selective inhibition of T-type Ca2+ channels by Ro 40-5967

1 reference

12 December 2020

Comparative study of elgodipine and nisoldipine on the contractile responses of various isolated blood vessels

1 reference

12 December 2020

In vitro effects of nifedipine, nisoldipine, and lacidipine on rat isolated coronary small arteries.

1 reference

12 December 2020

Practical relevance of the 24-hour trough: peak ratio of antihypertensive drugs

1 reference

12 December 2020

Comparative inhibitory effects of dihydropyridines on platelet aggregation, calcium uptake and cyclic AMP concentration

1 reference

12 December 2020

Pharmacokinetic Interactions with Calcium Channel Antagonists (Part II)

1 reference

12 December 2020

Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies

1 reference

12 December 2020

Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics

1 reference

12 December 2020

Have expert panel guidelines kept pace with new concepts in hypertension?

1 reference

12 December 2020

Anti-hypertensive drugs non-specifically reduce "spontaneous" activation of blood platelets

1 reference

12 December 2020

Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group

1 reference

12 December 2020

Cardioselectivity of calcium antagonists

1 reference

12 December 2020

The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

1 reference

12 December 2020

New Uses for Calcium Channel Blockers : Therapeutic Implications

1 reference

12 December 2020

Pharmacokinetic Interactions with Calcium Channel Antagonists (Part I)1

1 reference

12 December 2020

Inhibition of nisoldipine on bovine mesenteric arteries and veins and on human peripheral veins

1 reference

12 December 2020

Reduction of endothelin levels by the dihydropyridine calcium antagonist nisoldipine and a 'natural factor' in cultured human endothelial cells

1 reference

12 December 2020

Calcium channel blocker prevents stress-induced activation of renin and aldosterone in conscious pig

1 reference

12 December 2020

Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies

1 reference

12 December 2020

Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders

1 reference

12 December 2020

A study to investigate the comparative efficacy and tolerability of nisoldipine coat-core and atenolol in the treatment of mild to moderate hypertension

1 reference

12 December 2020

Comparative efficacy and tolerability of nisoldipine coat core and hydrochlorothiazide in mild-to-moderate hypertension

1 reference

12 December 2020

Interaction of citrus juices with felodipine and nifedipine

1 reference

12 December 2020

Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society

1 reference

12 December 2020

Effects of manidipine and other calcium antagonists on rat renal arcuate arteries

1 reference

12 December 2020

Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators

1 reference

12 December 2020

Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation.

1 reference

12 December 2020

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

12 December 2020

Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines.

1 reference

12 December 2020

Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice

1 reference

12 December 2020

[Comparison of the negative inotropic properties of nifedipine and nisoldipine using isovolumetric contractile parameters of the rat in vivo]

1 reference

12 December 2020

Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension

1 reference

12 December 2020

10.2165/00003495-199652020-00009

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

1019424269

0 references

1 reference